aap acquires rights on Adcon® from Wright Medical Technologies
aap´s Dutch subsidiary EMCM acted based on its innovative Hydrogel technology as producer of Adcon® L already before signing the agreement. Together with this product, successfully launched in a lot of countries already, aap takes over an established network of international distribution partners.
aap intends to achieve an FDA registration and to develop under the brand Adcon® a broader product portfolio in the sector of adhesion control (prevention of organic tissue adhesion) within the coming years.
For 2008 aap expects a revenue with Adcon® products of approx. EUR 1.5 million and a positive contribution margin to its results.